Your browser doesn't support javascript.
loading
Combination of novel HER2-targeting antibody 1E11 with trastuzumab shows synergistic antitumor activity in HER2-positive gastric cancer.
Ko, Bong-Kook; Lee, Sook-Yeon; Lee, Young-Ha; Hwang, In-Sik; Persson, Helena; Rockberg, Johan; Borrebaeck, Carl; Park, Dongeun; Kim, Kyu-Tae; Uhlen, Mathias; Lee, Jong-Seo.
Afiliación
  • Ko BK; AbClon Inc., #1403, Ace Twin Tower 1, 212-1, Guro-dong, Guro-gu, Seoul 152-779, Republic of Korea; School of Biological Sciences, Seoul National University, Seoul 152-747, Republic of Korea.
  • Lee SY; AbClon Inc., #1403, Ace Twin Tower 1, 212-1, Guro-dong, Guro-gu, Seoul 152-779, Republic of Korea.
  • Lee YH; AbClon Inc., #1403, Ace Twin Tower 1, 212-1, Guro-dong, Guro-gu, Seoul 152-779, Republic of Korea.
  • Hwang IS; AbClon Inc., #1403, Ace Twin Tower 1, 212-1, Guro-dong, Guro-gu, Seoul 152-779, Republic of Korea.
  • Persson H; Department of Immunotechnology, Lund University, Medicon Village, Lund, Sweden.
  • Rockberg J; School of Biotechnology, KTH Royal Institute of Technology, SE-106 91 Stockholm, Sweden.
  • Borrebaeck C; Department of Immunotechnology, Lund University, Medicon Village, Lund, Sweden.
  • Park D; School of Biological Sciences, Seoul National University, Seoul 152-747, Republic of Korea.
  • Kim KT; AbClon Inc., #1403, Ace Twin Tower 1, 212-1, Guro-dong, Guro-gu, Seoul 152-779, Republic of Korea. Electronic address: ktkim@abclon.com.
  • Uhlen M; School of Biotechnology, KTH Royal Institute of Technology, SE-106 91 Stockholm, Sweden.
  • Lee JS; AbClon Inc., #1403, Ace Twin Tower 1, 212-1, Guro-dong, Guro-gu, Seoul 152-779, Republic of Korea.
Mol Oncol ; 9(2): 398-408, 2015 Feb.
Article en En | MEDLINE | ID: mdl-25306393
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Gástricas / Receptor ErbB-2 / Anticuerpos Neutralizantes / Anticuerpos Monoclonales Humanizados / Anticuerpos Antineoplásicos / Antineoplásicos Límite: Humans Idioma: En Revista: Mol Oncol Asunto de la revista: BIOLOGIA MOLECULAR / NEOPLASIAS Año: 2015 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Gástricas / Receptor ErbB-2 / Anticuerpos Neutralizantes / Anticuerpos Monoclonales Humanizados / Anticuerpos Antineoplásicos / Antineoplásicos Límite: Humans Idioma: En Revista: Mol Oncol Asunto de la revista: BIOLOGIA MOLECULAR / NEOPLASIAS Año: 2015 Tipo del documento: Article Pais de publicación: Estados Unidos